kynurenic acid has been researched along with Learning Disabilities in 3 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Learning Disabilities: Conditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagbosu, CO | 1 |
| Evans, GC | 1 |
| Gulick, D | 1 |
| Suckow, RF | 1 |
| Bucci, DJ | 1 |
| Wood, ER | 1 |
| Bussey, TJ | 1 |
| Phillips, AG | 1 |
| Carli, M | 1 |
| Bonalumi, P | 1 |
| Samanin, R | 1 |
3 other studies available for kynurenic acid and Learning Disabilities
| Article | Year |
|---|---|
Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Excitatory Amino Acid Antagonists; Fear; Kynurenic | 2012 |
A glycine antagonist 7-chlorokynurenic acid attenuates ischemia-induced learning deficits.
Topics: Analysis of Variance; Animals; Cerebral Ventricles; Discrimination, Psychological; Glycine; Hippocam | 1993 |
WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid.
Topics: Animals; Excitatory Amino Acid Antagonists; Hippocampus; Injections; Kynurenic Acid; Learning Disabi | 1997 |